Related Experiment Video
Updated: Jun 19, 2026

10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
microRNAs and genetic diseases.
Nicola Meola1, Vincenzo Alessandro Gennarino, Sandro Banfi
1Telethon Institute of Genetics and Medicine (TIGEM), 80131 Naples, Italy. banfi@tigem.it.
Pathogenetics
|November 6, 2009
Summary
MicroRNAs (miRNAs) regulate gene expression and are implicated in human genetic diseases. Mutations affecting miRNA sequences, targets, or processing can lead to various disorders.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- MicroRNAs (miRNAs) are small RNA molecules that regulate gene expression post-transcriptionally.
- miRNAs bind to messenger RNAs, typically in the 3' untranslated region, to inhibit translation or promote degradation.
- Given their widespread regulatory roles, miRNAs are crucial in development and physiological processes.
Purpose of the Study:
- To review the evidence supporting the pathogenic role of miRNAs in human genetic diseases.
- To outline mutation mechanisms affecting miRNA function in genetic disorders.
- To discuss phenotypic consequences of miRNA alterations based on recent studies.
Main Methods:
- Review of existing literature on miRNA mutations and genetic diseases.
- Categorization of mutation types affecting miRNA function: sequence, target sites, and processing genes.
- Analysis of findings from animal models investigating miRNA alteration phenotypes.
Main Results:
- Mutations in miRNA genes, their target recognition sites, or miRNA processing machinery can cause human genetic disorders.
- Alterations in miRNA function are linked to diverse phenotypic consequences across various tissues and organs.
- Evidence suggests a broad spectrum of genetic diseases may arise from miRNA dysregulation.
Conclusions:
- miRNAs play a significant role in human health, and their dysfunction contributes to genetic diseases.
- Understanding miRNA-related mutations is crucial for diagnosing and potentially treating a range of genetic conditions.
- Further research is needed to fully elucidate the spectrum of diseases associated with miRNA alterations.
Related Concept Videos
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

